Latest News Releases From The Newsroom
Biogen-Sage's Zuranolone: FDA Says 'Yes' for PPD, 'No' for MDD
August 05th, 2023
Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) have received U.S. Food and Drug Administration (FDA) approval for ZURZUVAE (zuranolone) 50 mg, offering a groundbreaking 14-day oral treatment for postpartum depression (PPD) in a. Read more
ManpowerGroup Greenlit New Share Buyback Program; Boeing Gets $145.7M+ Order
August 04th, 2023
Shares of ManpowerGroup Inc. (NYSE: MAN) surged in after-hours trading following the company's announcement that its Board of Directors has greenlit a fresh share buyback program of up to 5.0 million shares of its common stock, which will be executed. Read more
President Biden: Bidenomics In Action
August 04th, 2023
President Joe Biden hailed the latest employment report as a testament to the success of his economic policies, commonly referred to as Bidenomics. With unemployment reaching a record low and the proportion of employed working-age Americans hitting a. Read more
AMC Networks Posts Mixed Results; Bullish View On Wayfair
August 04th, 2023
AMC Networks Inc. (Nasdaq: AMCX) reported Q2 2023 adjusted earnings per share (EPS) of $2.02, surpassing analysts' expectations of $1.60. However, the company reported quarterly revenues of $678.63 million, falling short of the consensus est. Read more
In the Spotlight: Fluor's Earnings and Tupperware's Debt Moves Share the Stage
August 04th, 2023
Fluor Corporation (NYSE: FLR) has reported adjusted earnings per share (EPS) of $0.76 for the second quarter of 2023, with revenues totaling $3.94 billion. These results significantly surpassed the consensus estimate of $0.43 EPS on revenues of $3.68. Read more
Mesoblast Faces Regulatory Setback; Nikola's Earnings: A Preview
August 04th, 2023
Mesoblast Limited (Nasdaq: MESO) has announced the receipt of a comprehensive response from the US Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) resubmission for remestemcel-L. The FDA's response stipulates the . Read more
Exceeding Forecasts: Booking Holdings and Trupanion's Q2 Earnings
August 03rd, 2023
Shares of Booking Holdings Inc. (Nasdaq: BKNG) experienced a remarkable after-hours surge of over 10% following the release of its second-quarter 2023 financial results. The company outperformed expectations with an earnings per share (EPS) of $37. Read more
SEC Obtains Emergency Relief to Halt Utah-Based Company's Crypto Asset Fraud Scheme Involving 18 Defendant
August 03rd, 2023
FOR IMMEDIATE RELEASE 2023-146 Washington D.C. / CRWE PRESS RELEASE / Aug. 3, 2023 - The Securities and Exchange Commission today announced that it obtained a temporary asset freeze, restraining order, and other emergency relief agains. Read more
NeuBase Makes Strategic Move; EZ Detect's Expanded Reach Fuels Biomerica
August 03rd, 2023
NeuBase Therapeutics, Inc. (Nasdaq: NBSE) announced a pause in its program development. Instead, NeuBase will explore strategic options, including acquisitions, mergers, and other transactions, with the goal of maximizing shareholder value. Accord. Read more
Q2 Earnings: Regeneron and Cigna Outperform Expectations
August 03rd, 2023
Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) surged over 5% in pre-market trading following an impressive second quarter 2023 earnings report. The company exceeded expectations, reporting adjusted earnings per share (EPS) of $10.24 and re. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025
Member Login